Literature DB >> 22202952

Comparison of experimental porous silicone implants and porous silicone implants.

JunHyuk Son1, Chang-sik Kim, JaeWook Yang.   

Abstract

BACKGROUND: To investigate the extent and pattern of fibrovascular ingrowth of porous silicone sphere implants compared to porous polyethylene implants.
METHODS: Experimental porous silicone sphere implants and porous polyethylene implants were implanted in the left socket of 20 New Zealand white rabbits after enucleation. Fibrovascular ingrowth and maturation was evaluated at 4 weeks and 8 weeks after implantation by histopathologic examination and scanning electron microscope.
RESULTS: At 4 weeks after surgery, porous polyethylene implants showed deeper fibrovascular ingrowth than porous silicone sphere implants; 42.4% versus 34.2% of radius of the implants respectively (p = 0.047). However there was no significant difference in the depth of fibrovascular ingrowth between the two groups at 8 weeks after implantation, although porous polyethylene implants showed deeper fibrovascular ingrowth than porous silicone sphere implants; 71.6% versus 63.6% (p = 0.102).
CONCLUSIONS: Porous silicone orbital implants demonstrated a comparable extent of fibrovascular ingrowth to that for porous polyethylene implants. Therefore, this new porous silicone sphere implant may be a good candidate to substitute for current porous implants at a lower cost.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22202952     DOI: 10.1007/s00417-011-1902-7

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  18 in total

1.  Fibrovascular ingrowth in porous ocular implants: the effect of material composition, porosity, growth factors, and coatings.

Authors:  W J Bigham; P Stanley; J M Cahill; R W Curran; A C Perry
Journal:  Ophthalmic Plast Reconstr Surg       Date:  1999-09       Impact factor: 1.746

2.  Infected aluminum oxide orbital implant.

Authors:  David R Jordan; Seymour Brownstein; J Robinson
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2006 Jan-Feb       Impact factor: 1.746

3.  Histopathologic evidence of fibrovascular ingrowth four weeks after placement of the hydroxyapatite orbital implant.

Authors:  C L Shields; J A Shields; R C Eagle; P De Potter
Journal:  Am J Ophthalmol       Date:  1991-03-15       Impact factor: 5.258

4.  Coralline hydroxyapatite as an ocular implant.

Authors:  J J Dutton
Journal:  Ophthalmology       Date:  1991-03       Impact factor: 12.079

5.  The new ocular implants.

Authors:  D G DURHAM
Journal:  Am J Ophthalmol       Date:  1949-01       Impact factor: 5.258

6.  Scanning electron microscopic examination of porous orbital implants.

Authors:  L A Mawn; D R Jordan; S Gilberg
Journal:  Can J Ophthalmol       Date:  1998-06       Impact factor: 1.882

7.  UK national survey of enucleation, evisceration and orbital implant trends.

Authors:  P Viswanathan; Mandeep S Sagoo; Jane M Olver
Journal:  Br J Ophthalmol       Date:  2006-12-06       Impact factor: 4.638

8.  The porous polyethylene (Medpor) spherical orbital implant: a retrospective study of 136 cases.

Authors:  Sean M Blaydon; Todd R Shepler; Russell W Neuhaus; William L White; John W Shore
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2003-09       Impact factor: 1.746

9.  Current trends in managing the anophthalmic socket after primary enucleation and evisceration.

Authors:  Grant W Su; Michael T Yen
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2004-07       Impact factor: 1.746

10.  Coralline hydroxyapatite orbital implant (bio-eye): experience with 158 patients.

Authors:  David R Jordan; Steven Gilberg; Ahmed Bawazeer
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2004-01       Impact factor: 1.746

View more
  1 in total

1.  Assessing the results of anophthalmic prostheses.

Authors:  Yoav Vardizer; Tamer Sobeh; Daphna Landau Prat; Guy J Ben Simon; Oren Tomkins-Netzer
Journal:  Indian J Ophthalmol       Date:  2021-07       Impact factor: 1.848

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.